For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Take care to avoid harm when prescribing NSAIDs to Māori and Pacific patients
+Practice
In print
PHARMACOTHERAPY
Take care to avoid harm when prescribing NSAIDs to Māori and Pacific patients
Friday 18 September 2020, 04:10 PM

Guidelines for osteoarthritis of the knee recommend NSAIDs, with minimal place for short-term opioids
Osteoarthritis is frustrating to treat, with analgesics having dwindling benefits and adverse effects to consider. Prescribing pharmacist Linda Bryant discusses the management of this complex condition using a Māori man as an example
Key points, Education and self-management are the cornerstones of management for osteoarthritis – explain that exercise is not harmful and the aim is to improve f, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.